NSW restrictions ‘too tough’ says pub baron Arthur Laundy

NSW restrictions ‘too tough’ says pub baron Arthur Laundy

0
Oct 1, 2020 – 6.15pmNSW pub baron and Financial Review Rich Lister Arthur Laundy has taken a swipe at COVID restrictions in his home state after selling the Swansea Hotel in Lake Macquarie for about $20 million.Mr Laundy, owner of Laundy Hotels which operates more than 20 venues in NSW including the Bells Hotel in…
Vanguard forfeits $100b ahead of Big Super showdown

Vanguard forfeits $100b ahead of Big Super showdown

0
ExclusiveOct 1, 2020 – 6.05pmThe world's second biggest asset manager, Vanguard, is gearing up to disrupt Australia's big superannuation funds by announcing it will return tens of billions of dollars it now invests on behalf of their members and instead compete for the money directly.The $8.9 trillion investment manager, described as the "Amazon of financial…
‘Traumatised’: Aged care virus planning was insufficient, confused

‘Traumatised’: Aged care virus planning was insufficient, confused

0
Oct 1, 2020 – 5.57pmThe Coalition government's handling of the COVID-19 threat to Australians living in aged care was "insufficient" and suffered from confused and inconsistent messaging, a new report has found.Releasing a special report into the coronavirus crisis, the aged care royal commission warned a comprehensive, defined and consolidated plan to manage outbreaks in…
A judge has approved an $800 million settlement for victims of the Las Vegas shooting – CNN

A judge has approved an $800 million settlement for victims of the Las Vegas...

0
A judge approved a $800 million settlement on Wednesday for victims of the Las Vegas mass shooting, which is considered the deadliest mass shooting in modern US history.
Former execs say Toll was all tactics, no strategy

Former execs say Toll was all tactics, no strategy

0
InvestigationLife And LuxuryHealth And WellnessLeadership lessonsIn the second part of a series on logistics group Toll, Aaron Patrick describes an arrogant culture that refused to accept bad news.Toll chief executive Brian Kruger, the former CFO, struggled to assert his authority over the logistics group. Arsineh HouspianOct 1, 2020 – 12.00amThis looks like a science fair experiment,"…
4D Medical soars 12pc on quick TGA approval

4D Medical soars 12pc on quick TGA approval

0
Sep 30, 2020 – 1.25pmLocal lung-imaging medical technology company 4D Medical has had its lung airflow imaging device approved by the Therapeutic Goods Administration six months ahead of schedule.The news catapulted the company's share price up almost 12 per cent in morning trade on Wednesday, with the stock trading at $1.70 at 12.30pm.4D Medical founder…
AMP announces sweeping redundancies

AMP announces sweeping redundancies

0
BreakingSep 30, 2020 – 12.20pmAMP has announced a sweeping program that will trigger redundancies of up to 20 per cent in both its AMP Capital asset management arm and in the AMP Australia wealth management division.AMP is exploring options to spin off parts of the company.  Louie DouvisChief executive Francesco De Ferrari sticks to his…
Why Google wanted Audrey Zibelman

Why Google wanted Audrey Zibelman

0
OpinionThe AEMO boss knows how to run an energy grid where a new rooftop solar system is added every six minutes and that will help in her new job. Australia is a 'postcard from the future', she says.Ben PotterCompanies editorMore than four years ago Ivor Frischknecht, then chief executive of the Australian Renewable Energy Agency,…
Dow Jones Futures Higher Ahead Of Trump-Biden Debate; Regeneron Jumps On Coronavirus Drug News – Investor’s Business Daily

Dow Jones Futures Higher Ahead Of Trump-Biden Debate; Regeneron Jumps On Coronavirus Drug News...

0
Dow Jones futures were in focus late Tuesday ahead of the U.S presidential debate between President Trump and Joe Biden. Beyond Meat surged to a breakout.
Katie Porter tore into pharma executive for price hikes on cancer drug – Business Insider

Katie Porter tore into pharma executive for price hikes on cancer drug – Business...

0
"The drug didn't get any better, the cancer patients didn't get any better, you just got better at making money," Porter said during the hearing.